BioSpace News Archive

XOMA Corporation announced today its Chairman and Chief Executive Officer, Jim Neal, will present at Oppenheimer’s 32nd Annual Healthcare Conference (virtual) on Thursday, March 17, 2022, at 12:40 PM ET.

Applied Therapeutics, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2021.

Dyne Therapeutics, Inc. today reported financial results for the fourth quarter and full year 2021 and recent business highlights.

Graybug Vision, Inc. provided an update on recent corporate developments and reported financial results for the full year ended December 31, 2021.

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Wednesday, March 30, 2022, 5:00 p.m. ET.

Inari Medical, Inc. today announced the commencement of an underwritten public offering of 2,000,000 shares of its common stock.

PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Cleveland Clinic today announced a five-year strategic collaboration that will focus on leveraging PathAI’s quantitative pathology algorithms both to conduct new translational research and for use as clinical diagnostics in multiple disease areas.

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced it has entered into an agreement with KBI Biopharma, Inc. (“KBI”) for the process transfer, process optimization and cGMP manufacturing of the Company’s intranasal vaccine candidate NT-CoV2-1.

Tempest Therapeutics, Inc. announced that management will present at the 32nd Annual Oppenheimer Healthcare Conference on Thursday, March 17, 2022 at 10:40 a.m. ET.

Clade Therapeutics, a biopharmaceutical company focused on discovering and delivering scalable, off-the-shelf, next-generation stem cell-based medicines, announced the appointment of Derek Hei, Ph.D., as its Chief Technology Officer.